Showing results (141-150 of 172) with videos related to

Sort By:
Pageof 18
The Journal of Thoracic and Cardiovascular Surgery|April 1, 1978
Chylothorax and chylopericardial tamponade following Blalock-Taussig anastomosisE P Hargus, S D Carson, R L McGrath, et al.
Journal of Hematotherapy & Stem Cell Research|May 17, 2000
Pharmacokinetics and in vivo effects of a six-base phosphorothioate oligodeoxynucleotide with anticancer and hematopoietic activities in swineJ E Mata, J D Jackson, S S Joshi, et al.
Cancer|August 15, 1990
The coagulopathy of childhood leukemia. Thrombin activation or primary fibrinolysis?T C Abshire, S H Gold, L F Odom, et al.
Annals of Surgery|July 1, 1978
Colon perforation after kidney transplantationS D Carson, R A Krom, K Uchida, et al.
The American Journal of Pathology|May 1, 1992
Hemagglutination and graft-versus-host disease in the severe combined immunodeficiency mouse lymphoproliferative disease modelS J Pirruccello, H Nakamine, K W Beisel, et al.
Blood|August 15, 1992
OMA-AML-1: a leukemic myeloid cell line with CD34+ progenitor and CD15+ spontaneously differentiating cell compartmentsS J Pirruccello, J D Jackson, M S Lang, et al.
International Journal of Cancer|February 20, 1991
SCID mouse model of Epstein-Barr virus-induced lymphomagenesis of immunodeficient humansD T Purtilo, K Falk, S J Pirruccello, et al.
Toxicology and Applied Pharmacology|May 1, 1997
A hexameric phosphorothioate oligonucleotide telomerase inhibitor arrests growth of Burkitt's lymphoma cells in vitro and in vivoJ E Mata, S S Joshi, B Palen, et al.
The American Journal of Pathology|January 1, 1993
Characterization of clonality of Epstein-Barr virus-induced human B lymphoproliferative disease in mice with severe combined immunodeficiencyH Nakamine, A S Masih, M Okano, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|October 1, 1991
Hematopathologic features of Epstein-Barr virus-induced human B-lymphoproliferation in mice with severe combined immunodeficiency. A model of lymphoproliferative diseases in immunocompromised patientsH Nakamine, M Okano, Y Taguchi, et al.
Pageof 18